Session Details
Luncheon Seminar 5
One year and eight months since the clinical implementation of anti-Aβ antibody drugs ―Now the role of MRI is being reconsidered―
Fri. Aug 29, 2025 12:30 PM - 1:20 PM JST
Fri. Aug 29, 2025 3:30 AM - 4:20 AM UTC
Fri. Aug 29, 2025 3:30 AM - 4:20 AM UTC
Room 5(Arcrea HIMEJI, 4F 408)
Chair: Yukio Miki(Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University)
Sponsored by Eisai Co., Ltd.／Biogen Japan Ltd.
[LS05-1]One year and eight months since the clinical implementation of anti-Aβ antibody drugs ―Now the role of MRI is being reconsidered―
○Aya Tokumaru (Department of Diagnostic Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology)